Thermo Fisher Scientific (TMO) valuation history
Historically high
As of
TMO's EV/EBITDA of 26.7x is the highest available weekly reading from the last five years.
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 24.9× | 95% | |
| 22.4× | 61% | |
| 22.9× | 82% | |
| 19.8× | 36% | |
| 21.0× | 66% | |
| 24.2× | 91% | |
| 21.6× | 93% | |
| 18.3× | 43% | |
| 20.7× | 98% | |
| 17.8× | 73% |
Loading related research…
About this history
- What is TMO's current EV/EBITDA?
- TMO's EV/EBITDA of 26.7x is the highest available weekly reading from the last five years.
- What is TMO's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 21.6× over the last five years. Available history contains 859 weekly observations from May 10, 2010 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.